Article Versions Notes

Zhou L, Zheng C, Ding S, Wang Z, Yang Y, Wang Y, He G, Fu S, Deng X. Lovastatin Targets the USP14–Survivin Axis to Suppress Triple-Negative Breast Cancer via Ubiquitin-Mediated Proteasomal Degradation. Cells. 2025; 14(11):816. https://doi.org/10.3390/cells14110816

Zhou, Li, Chanjuan Zheng, Siyu Ding, Zhiyu Wang, Yiyuan Yang, Yian Wang, Guangchun He, Shujun Fu, and Xiyun Deng. 2025. "Lovastatin Targets the USP14–Survivin Axis to Suppress Triple-Negative Breast Cancer via Ubiquitin-Mediated Proteasomal Degradation" Cells 14, no. 11: 816. https://doi.org/10.3390/cells14110816

Zhou, L., Zheng, C., Ding, S., Wang, Z., Yang, Y., Wang, Y., He, G., Fu, S., & Deng, X. (2025). Lovastatin Targets the USP14–Survivin Axis to Suppress Triple-Negative Breast Cancer via Ubiquitin-Mediated Proteasomal Degradation. Cells, 14(11), 816. https://doi.org/10.3390/cells14110816